More tools:Markets·Screener·Research·Chat

Medpace Holdings, Inc. Common Stock (MEDP) Financial Statements

Medpace Holdings, Inc. Common Stock
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG0065B7K40
XNAS · usd
590.89▼ 0.40 (-0.07%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close591.29
Day's Range587.09 – 596.98
52-Week Range372.95 – 677.90
Volume185.1K
Avg Volume235.4K
Share Statistics
Shares Outstanding
Employees6,300
ExchangeXNAS
Listed2016-08-11
Share count as of July 17, 2026
Loading Income Statement…
Key questions about Medpace Holdings, Inc. Common Stock (MEDP)
What is Medpace Holdings, Inc. Common Stock's Market Cap?
Medpace Holdings, Inc. Common Stock's Market Cap is $16.5B, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Trailing P/E?
Medpace Holdings, Inc. Common Stock's Trailing P/E is 33.6×, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Price / Sales?
Medpace Holdings, Inc. Common Stock's Price / Sales is 5.9×, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Revenue (TTM)?
Medpace Holdings, Inc. Common Stock's Revenue (TTM) is $2.8B, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Net Income (TTM)?
Medpace Holdings, Inc. Common Stock's Net Income (TTM) is $491.5M, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's EBITDA?
Medpace Holdings, Inc. Common Stock's EBITDA is $611.2M, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Diluted EPS (TTM)?
Medpace Holdings, Inc. Common Stock's Diluted EPS (TTM) is 17.61, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's EBITDA Margin?
Medpace Holdings, Inc. Common Stock's EBITDA Margin is 22.0%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue, net (includes $4.7 million and $16.9 million with related parties for the three months ended June 30, 2026 and 2025, respectively, and $12.0 million and $30.7 million with related parties for the six months ended June 30, 2026 and 2025, respectively)
YoY growth+26.6%+31.7%+23.7%
Operating expenses:
Total direct costs
Selling, general and administrative
Depreciation
Amortization
Total operating expenses
% of revenue79.2%80.0%78.5%
Income from operations
% of revenue20.8%20.0%21.5%
Other income (expense), net:
Miscellaneous (expense) income, net
Interest income, net
Total other income (expense), net
Income before income taxes
Income tax provision
Net income
% of revenue17.2%17.5%16.8%
Net income per share attributable to common shareholders:
Basic (in dollars per share)
Diluted (in dollars per share)